Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1335553
PUBLISHER: KBV Research | PRODUCT CODE: 1335553
Europe Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 124 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Digital Dose Inhaler Market would witness market growth of 19.1% CAGR during the forecast period (2023-2030).
The market is experiencing significant technological advancements that are revolutionizing inhalation therapy devices such as meters inhalers combined with an e-dose counter, internet-connected and compact inhalers, among others. To boost medication adherence and confirm that patients receive the correct dosage, the leading market participants primarily focus on connectivity technology. In addition, the rising demand for technologically advanced features such as patient monitoring and seamless data transfer adds the necessary elements to accelerate market growth.
Patients can self-administer using a digital dose inhaler by rapidly inhaling an aerosolized medication into their airways following a predetermined dose. Digital inhalers include sensors that monitor inspiratory flow and identify inhalers utilize following dose management and release. There are numerous varieties of digital dose inhalers on the market, including metric dose inhalers (MDI) and dry powder inhalers (DPI).
In England, smoking is one of the leading causes of health disparities, disproportionately impacting disadvantaged communities and groups. In 2019, approximately 13.9% of adults in England smoked, or about 6 million persons. In England, smoking is one of the primary preventable causes of disease and premature mortality, accounting for approximately 74,600 fatalities annually. Additionally, one in four hospitalized patients is a smoker. The prevalence of respiratory disorders will also increase in the region as the number of tobacco users rises. In addition, the prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million, and it is anticipated to rise to 2.8 million by 2025. There needs to be more information regarding COPD management in private healthcare settings. These circumstances may increase the demand for products like digital dose inhalers.
The Germany market dominated the Europe Digital Dose Inhaler Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,045.8 million by 2030. The UK market is exhibiting a CAGR of 18.1% during (2023 - 2030). Additionally, The France market would experience a CAGR of 20% during (2023 - 2030).
Based on Product, the market is segmented into Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI). Based on Type, the market is segmented into Branded Medication, and Generic Medication. Based on Indication, the market is segmented into COPD, Asthma, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sensirion AG, Teva Pharmaceuticals Industries Ltd., OPKO Health, Inc., Propeller Health (ResMed, Inc.), Novartis AG, AstraZeneca PLC, Glenmark Pharmaceuticals Limited, Beximco Pharmaceuticals Ltd., GlaxoSmithKline PLC and Mundipharma Deutschland GmbH & Co. KG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
By Type
- Branded Medication
- Generic Medication
By Indication
- COPD
- Asthma
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Sensirion AG
- Teva Pharmaceuticals Industries Ltd.
- OPKO Health, Inc.
- Propeller Health (ResMed, Inc.)
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Beximco Pharmaceuticals Ltd.
- GlaxoSmithKline PLC
- Mundipharma Deutschland GmbH & Co. KG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Digital Dose Inhaler Market, by Product
- 1.4.2 Europe Digital Dose Inhaler Market, by Type
- 1.4.3 Europe Digital Dose Inhaler Market, by Indication
- 1.4.4 Europe Digital Dose Inhaler Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Force Analysis
Chapter 4. Strategies Deployed in Digital Dose Inhaler Market
Chapter 5. Europe Digital Dose Inhaler Market by Product
- 5.1 Europe Metered Dose Inhaler (MDI) Market by Country
- 5.2 Europe Dry Powder Inhaler (DPI) Market by Country
Chapter 6. Europe Digital Dose Inhaler Market by Type
- 6.1 Europe Branded Medication Market by Country
- 6.2 Europe Generic Medication Market by Country
Chapter 7. Europe Digital Dose Inhaler Market by Indication
- 7.1 Europe COPD Market by Country
- 7.2 Europe Asthma Market by Country
- 7.3 Europe Others Market by Country
Chapter 8. Europe Digital Dose Inhaler Market by Country
- 8.1 Germany Digital Dose Inhaler Market
- 8.1.1 Germany Digital Dose Inhaler Market by Product
- 8.1.2 Germany Digital Dose Inhaler Market by Type
- 8.1.3 Germany Digital Dose Inhaler Market by Indication
- 8.2 UK Digital Dose Inhaler Market
- 8.2.1 UK Digital Dose Inhaler Market by Product
- 8.2.2 UK Digital Dose Inhaler Market by Type
- 8.2.3 UK Digital Dose Inhaler Market by Indication
- 8.3 France Digital Dose Inhaler Market
- 8.3.1 France Digital Dose Inhaler Market by Product
- 8.3.2 France Digital Dose Inhaler Market by Type
- 8.3.3 France Digital Dose Inhaler Market by Indication
- 8.4 Russia Digital Dose Inhaler Market
- 8.4.1 Russia Digital Dose Inhaler Market by Product
- 8.4.2 Russia Digital Dose Inhaler Market by Type
- 8.4.3 Russia Digital Dose Inhaler Market by Indication
- 8.5 Spain Digital Dose Inhaler Market
- 8.5.1 Spain Digital Dose Inhaler Market by Product
- 8.5.2 Spain Digital Dose Inhaler Market by Type
- 8.5.3 Spain Digital Dose Inhaler Market by Indication
- 8.6 Italy Digital Dose Inhaler Market
- 8.6.1 Italy Digital Dose Inhaler Market by Product
- 8.6.2 Italy Digital Dose Inhaler Market by Type
- 8.6.3 Italy Digital Dose Inhaler Market by Indication
- 8.7 Rest of Europe Digital Dose Inhaler Market
- 8.7.1 Rest of Europe Digital Dose Inhaler Market by Product
- 8.7.2 Rest of Europe Digital Dose Inhaler Market by Type
- 8.7.3 Rest of Europe Digital Dose Inhaler Market by Indication
Chapter 9. Company Profiles
- 9.1 Sensirion AG
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
- 9.2 Teva Pharmaceutical Industries Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 OPKO Health, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
- 9.4 Propeller Health (ResMed, Inc.)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
- 9.5 Novartis AG
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Approvals and Trials:
- 9.5.6 SWOT Analysis
- 9.6 AstraZeneca PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Approvals and Trials:
- 9.6.6 SWOT Analysis
- 9.7 Glenmark Pharmaceuticals Limited
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
- 9.8 Beximco Pharmaceuticals Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Research & Development Expenses
- 9.8.4 SWOT Analysis
- 9.9 GlaxoSmithKline PLC (GSK)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
- 9.10. Mundipharma Deutschland GmbH & Co. KG
- 9.10.1 Company Overview
- 9.10.2 SWOT Analysis
LIST OF TABLES
- TABLE 1 Europe Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 2 Europe Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 3 Europe Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 4 Europe Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 5 Europe Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
- TABLE 6 Europe Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
- TABLE 7 Europe Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
- TABLE 8 Europe Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
- TABLE 9 Europe Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 10 Europe Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 11 Europe Branded Medication Market by Country, 2019 - 2022, USD Million
- TABLE 12 Europe Branded Medication Market by Country, 2023 - 2030, USD Million
- TABLE 13 Europe Generic Medication Market by Country, 2019 - 2022, USD Million
- TABLE 14 Europe Generic Medication Market by Country, 2023 - 2030, USD Million
- TABLE 15 Europe Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 16 Europe Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 17 Europe COPD Market by Country, 2019 - 2022, USD Million
- TABLE 18 Europe COPD Market by Country, 2023 - 2030, USD Million
- TABLE 19 Europe Asthma Market by Country, 2019 - 2022, USD Million
- TABLE 20 Europe Asthma Market by Country, 2023 - 2030, USD Million
- TABLE 21 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 22 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 23 Europe Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
- TABLE 24 Europe Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
- TABLE 25 Germany Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 26 Germany Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 27 Germany Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 28 Germany Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 29 Germany Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 30 Germany Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 31 Germany Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 32 Germany Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 33 UK Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 34 UK Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 35 UK Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 36 UK Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 37 UK Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 38 UK Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 39 UK Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 40 UK Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 41 France Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 42 France Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 43 France Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 44 France Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 45 France Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 46 France Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 47 France Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 48 France Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 49 Russia Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 50 Russia Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 51 Russia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 52 Russia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 53 Russia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 54 Russia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 55 Russia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 56 Russia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 57 Spain Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 58 Spain Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 59 Spain Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 60 Spain Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 61 Spain Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 62 Spain Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 63 Spain Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 64 Spain Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 65 Italy Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 66 Italy Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 67 Italy Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 68 Italy Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 69 Italy Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 70 Italy Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 71 Italy Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 72 Italy Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 73 Rest of Europe Digital Dose Inhaler Market, 2019 - 2022, USD Million
- TABLE 74 Rest of Europe Digital Dose Inhaler Market, 2023 - 2030, USD Million
- TABLE 75 Rest of Europe Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
- TABLE 76 Rest of Europe Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
- TABLE 77 Rest of Europe Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
- TABLE 78 Rest of Europe Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
- TABLE 79 Rest of Europe Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
- TABLE 80 Rest of Europe Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
- TABLE 81 Key Information - Sensirion AG
- TABLE 82 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 83 Key Information - OPKO Health, Inc.
- TABLE 84 Key Information - Propeller Health
- TABLE 85 Key Information - Novartis AG
- TABLE 86 KEY INFORMATION - AstraZeneca PLC
- TABLE 87 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 88 Key Information - Beximco Pharmaceuticals Ltd.
- TABLE 89 Key Information - GlaxoSmithKline PLC
- TABLE 90 Key Information - Mundipharma Deutschland GmbH & Co. KG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Europe Digital Dose Inhaler Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors digital dose inhaler market
- FIG 4 Porter's Five Force Analysis: Digital Dose Inhaler Market
- FIG 5 Europe Digital Dose Inhaler Market share by Product, 2022
- FIG 6 Europe Digital Dose Inhaler Market share by Product, 2030
- FIG 7 Europe Digital Dose Inhaler Market by Product, 2019 - 2030, USD Million
- FIG 8 Europe Digital Dose Inhaler Market share by Type, 2022
- FIG 9 Europe Digital Dose Inhaler Market share by Type, 2030
- FIG 10 Europe Digital Dose Inhaler Market by Type, 2019 - 2030, USD Million
- FIG 11 Europe Digital Dose Inhaler Market share by Indication, 2022
- FIG 12 Europe Digital Dose Inhaler Market share by Indication, 2030
- FIG 13 Europe Digital Dose Inhaler Market by Indication, 2019 - 2030, USD Million
- FIG 14 Europe Digital Dose Inhaler Market share by Country, 2022
- FIG 15 Europe Digital Dose Inhaler Market share by Country, 2030
- FIG 16 Europe Digital Dose Inhaler Market by Country, 2019 - 2030, USD Million
- FIG 17 SWOT Analysis: SENSIRION AG
- FIG 18 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
- FIG 19 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
- FIG 20 SWOT Analysis: OPKO Health, Inc.
- FIG 21 SWOT Analysis: Propeller Health
- FIG 22 SWOT Analysis: Novartis AG
- FIG 23 SWOT Analysis: AstraZeneca PLC
- FIG 24 SWOT Analysis: Glenmark Pharmaceuticals Ltd.
- FIG 25 SWOT Analysis: Beximco Pharmaceuticals Ltd.
- FIG 26 SWOT Analysis: GlaxoSmithKline PLC
- FIG 27 SWOT Analysis: Mundipharma Deutschland GmbH & Co. KG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.